Lupin Ltd.

Industry · 15 registered clinical trials — 4 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders Myotonic Disorders	—	2025-09-30
Enrolling By Invitation	An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Pat Myotonic Dystrophy	Phase 3	2025-09-12
Recruiting	An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared t Myotonia	Phase 3	2025-09-03
Recruiting	The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Myotonic Dystrophy	Phase 3	2025-02-13
Active Not Recruiting	Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study. Myotonic Disorders	N/A	2021-11-05
Completed	Open Label Study in Adolescents and Children With Myotonic Disorders Myotonic Dystrophy	Phase 3	2021-09-03
Withdrawn	Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type Myotonic Dystrophy Type 1 and Type 2	Phase 3	2021-09-03
Active Not Recruiting	An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders Myotonic Dystrophy	—	2020-12-17
Completed	A Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors	Phase 1	2020-09-22
Completed	Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucenti Neovascular Age-related Macular Degeneration	Phase 3	2020-09-14
Completed	Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast C Breast Cancer	Phase 4	2018-03-06
Completed	A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female S Healthy	Phase 1	2014-05-01
Completed	Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets Pharmacokinetic Study	Phase 1	2008-09-01
Completed	Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of Gla Pharmacokinetic Study	Phase 1	2008-09-01
Completed	Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of Gla Pharmacokinetic Study	Phase 1	2008-09-01